Matt Campbell MD, MS

We are pleased to announce Dr. Omar Alhalabi (@OAlhalabiMD) as a Speaker at How I Treat Bladder Cancer 2026. Dr. Alhalabi is a medical oncologist and faculty member at MD Anderson Cancer Center with a research focus on the genomic and molecular drivers of bladder cancer. His work particularly explores cell cycle alterations and therapeutic vulnerabilities in conventional and neuroendocrine urothelial cancer, while leading several clinical trials in both early and advanced-stage disease. His expertise in translational research and precision oncology will bring valuable perspective to this international educational discussion on contemporary bladder cancer management. Additional faculty announcements will follow soon. Register here: docs.google.com/forms/d/e/1FAI… #HowITreatBladderCancer #BladderCancer #GUOncology #MedicalOncology

😁 Excited to share our work on #BladderCancer, now online @CD_AACR! Led by brilliant postdoc Kai Yu🌟, jointly with Dr. JJ Gao @UTMDAnderson Huge thanks to @TaliLev123 & reviewers — only 4 months from submission to accepted manuscript online! Incredible! doi.org/10.1158/2159-8…

@UroCancer @Marriott I figured you would just go for Mountain Dew and speed run AUA

@Marriott what happened to the partnership with Coke? This Diet Pepsi just doesn’t cut it. #aua2026

@GEVaughan1 Thank you @GEVaughan1 and the @KidneyCancer family

Happy birthday, @DocMattCampbell! It’s inspiring to see how much you care for your family and your patients. We want you to know the KCA is just as proud to have you with us!

Early detection for bladder cancer is crucial, and in our latest Cancerwise podcast episode, Drs. Ashish Kamat and Matt Campbell discuss the signs to look for. Listen to the full episode: spr.ly/6010BBgD4g @docmattcampbell @urodocash #EndCancer

@ChapinMD @UTMDAnderson @IUuro @nnavai @jdhdavis @UroDocAsh @JustinRGregg @KKBree @BCottaMD @CurtisPettaway1 @lislycherymd @DrByronLee @sgswisher Greatly enjoyed the presentation. Appreciate Dr Masterson visiting and highlighting Indiana’s approach to a number of complicated management scenarios in GCT. @IU_UroOnc

Excellent grand rounds this morning @UTMDAnderson by our VP, Tim Masterson @IUuro on contemporary testis cancer management. Tremendous experience + practical insight shared on multi-D care, surgical decision making + optimizing outcomes. #oncsurgery

@UroDocAsh Enjoyed spending my time @UroDocAsh. Incredible progress in bladder cancer. Thank you to the CancerWise podcast for hosting us.

Bladder cancer care looks very different today than it did just a few years ago. Patients deserve to know the options. Sat down with @DocMattCampbell to break it all down in plain language. We cover everything from the critical first steps in diagnosis to breakthrough treatments and the future of bladder preservation. If you or a loved one is navigating a diagnosis, or you want to understand the current state of #bladdercancer care, this @CancerWise podcast is for you. 🎙️ #BladderCancerAwarenessMonth #OncSurgery @UTMDAnderson youtu.be/lH8-Gb4acWU?si…

@emanuele_crupi @ASCO @ConquerCancerFd @UTMDAnderson @OAlhalabiMD @UroDocAsh @PavlosMsaouel @mjmoussa_ @DrZachariahT @oncodaily @glovedoc @BladderCancerUS @CYJiangMD Very well deserved! Proud of you

Honored to receive this prestigious recognition from @ASCO & @ConquerCancerFd! Grateful to the Stadler family for their generosity. Deeply thankful to my @UTMDAnderson family & mentors, Drs. JJ Gao and Siefker-Radtke, for their unwavering support. #EndCancer #ASCO26

Grateful to @GUOncologyNow team for highlighting our study, published in @JCOPO_ASCO! Appreciate the mentorship of @DocMattCampbell & @OAlhalabiMD, in this work examining the meaningful benefit of single-agent ICIs in advanced UTUC with dMMR/MSI-H! 🔗: ascopubs.org/doi/10.1200/PO…

1/5 New in @CCR_AACR: Results of the 1st prospective trial of a targeted agent in #SMARCB1-deficient #RenalMedullaryCarcinoma (RMC). We tested ixazomib + gemcitabine + doxorubicin in 30 patients aacrjournals.org/clincancerres/… #endRMC #MsaouelLab

@TiansterZhang @DrPaulNguyen @NRGonc @ChapinMD @DocMattCampbell @Daniel_J_George @QianJanieQin @JVentoMD @CharlesJiangMD @MutlaySayan

@TiansterZhang @DrPaulNguyen @NRGonc @ChapinMD @DocMattCampbell @Daniel_J_George @QianJanieQin @JVentoMD @CharlesJiangMD @MutlaySayan Absolute pleasure to hangout with @DrPaulNguyen and to hear his work… and to feed our conversations directly into LLMs for jokes

@hannahdzmd showing early results from the #ODYSSEY study, reflecting prospective observational data for how we treat kidney cancer. #ChrisWood26 @DukeGUCancer

@DrPaulNguyen our distinguished #RadOnc guest w fantastic overview of high risk #prostatecancer — decades of his work - highlighting #ENZARAD, pelvic LN XRT, decipher & ArteraAI influencing treatmt choices. Awaiting @NRGonc #GU009! #ChrisWood26 Thanks for visiting Texas Paul!

@TiansterZhang @Daniel_J_George @ChapinMD @ndesai2005 @DukeGUCancer @utswcancer @UTMDAnderson Thank you for joining Dan! Fantastic talk, appreciate you joining us in San Antonio.

Congrats @Daniel_J_George! Distinguished GU med onc guest at our Chris Wood Uro-Onc meeting this year. Pleased to organize w @ChapinMD @DocMattCampbell @ndesai2005 et al. @DukeGUCancer @utswcancer @UTMDAnderson

@ChapinMD @UroCancer @UroOnc @TiansterZhang @ndesai2005 @cgwoodMD @C_Woody18 @CurtisPettaway1 @KKBree @JustinRGregg @nnavai @jdhdavis @DrByronLee @UroDocAsh @BCottaMD @OLWMD @lislycherymd Scott was the perfect blend of truth, knowledge, humor, and life lessons. Just show up! Loved it. Thank you for being a constant presence at this conference. Chris Wood would fully approve. I could hear him say “Really!” after a good number of the slides.

@UroCancer receives the David Swanson Distinguished alumnus award Practical advice to @UroOnc fellows, Pragmatic trial designs, and a little bit of laughter Congrats on an impactful career @DocMattCampbell @TiansterZhang @ndesai2005 @cgwoodMD @C_Woody18 #oncsurgery